RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis
FRA:RHK - DE0007042301 - Common Stock
11.9 EUR
-0.1 (-0.83%)
Taking everything into account, RHK scores 5 out of 10 in our fundamental rating. RHK was compared to 28 industry peers in the Health Care Providers & Services industry. While RHK has a great health rating, its profitability is only average at the moment. RHK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
RHK had positive earnings in the past year.
In the past year RHK had a positive cash flow from operations.
In the past 5 years RHK has always been profitable.
Each year in the past 5 years RHK had a positive operating cash flow.
1.2 Ratios
RHK has a Return On Assets (2.34%) which is comparable to the rest of the industry.
RHK's Return On Equity of 3.35% is on the low side compared to the rest of the industry. RHK is outperformed by 64.29% of its industry peers.
RHK's Return On Invested Capital of 2.75% is on the low side compared to the rest of the industry. RHK is outperformed by 67.86% of its industry peers.
RHK had an Average Return On Invested Capital over the past 3 years of 2.34%. This is below the industry average of 6.48%.
The last Return On Invested Capital (2.75%) for RHK is above the 3 year average (2.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.35% | ||
| ROIC | 2.75% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
1.3 Margins
RHK has a Profit Margin (2.72%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of RHK has declined.
With a Operating Margin value of 3.04%, RHK is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
RHK's Operating Margin has declined in the last couple of years.
RHK's Gross Margin of 66.44% is fine compared to the rest of the industry. RHK outperforms 67.86% of its industry peers.
In the last couple of years the Gross Margin of RHK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.04% | ||
| PM (TTM) | 2.72% | ||
| GM | 66.44% |
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RHK is destroying value.
Compared to 1 year ago, RHK has about the same amount of shares outstanding.
Compared to 5 years ago, RHK has about the same amount of shares outstanding.
Compared to 1 year ago, RHK has an improved debt to assets ratio.
2.2 Solvency
RHK has an Altman-Z score of 2.97. This is not the best score and indicates that RHK is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.97, RHK is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
The Debt to FCF ratio of RHK is 2.62, which is a good value as it means it would take RHK, 2.62 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.62, RHK belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
RHK has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of RHK (0.09) is better than 92.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 2.62 | ||
| Altman-Z | 2.97 |
ROIC/WACC0.43
WACC6.4%
2.3 Liquidity
A Current Ratio of 2.23 indicates that RHK has no problem at all paying its short term obligations.
RHK has a Current ratio of 2.23. This is amongst the best in the industry. RHK outperforms 92.86% of its industry peers.
RHK has a Quick Ratio of 2.14. This indicates that RHK is financially healthy and has no problem in meeting its short term obligations.
RHK's Quick ratio of 2.14 is amongst the best of the industry. RHK outperforms 92.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
RHK shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.07%.
Measured over the past 5 years, RHK shows a small growth in Earnings Per Share. The EPS has been growing by 0.03% on average per year.
RHK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.58%.
RHK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.12% yearly.
EPS 1Y (TTM)-7.07%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-31.25%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.34%
3.2 Future
The Earnings Per Share is expected to grow by 12.28% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.94% on average over the next years.
EPS Next Y9.14%
EPS Next 2Y10.96%
EPS Next 3Y11.09%
EPS Next 5Y12.28%
Revenue Next Year5.98%
Revenue Next 2Y4.97%
Revenue Next 3Y6.5%
Revenue Next 5Y5.94%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
RHK is valuated rather expensively with a Price/Earnings ratio of 19.83.
Compared to the rest of the industry, the Price/Earnings ratio of RHK is on the same level as its industry peers.
RHK is valuated rather cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.44 indicates a correct valuation of RHK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RHK is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, RHK is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.83 | ||
| Fwd PE | 15.44 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RHK is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.93 | ||
| EV/EBITDA | -0.02 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RHK does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.17
PEG (5Y)583.23
EPS Next 2Y10.96%
EPS Next 3Y11.09%
5. Dividend
5.1 Amount
With a yearly dividend of 0.83%, RHK is not a good candidate for dividend investing.
RHK's Dividend Yield is comparable with the industry average which is at 2.70.
Compared to an average S&P500 Dividend Yield of 2.32, RHK's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y10.96%
EPS Next 3Y11.09%
FRA:RHK (8/29/2025, 7:00:00 PM)
11.9
-0.1 (-0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.68%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap796.82M
Analysts45.71
Price Target14.45 (21.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.97%
PT rev (3m)1.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.93%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2%
Revenue NY rev (3m)-2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.83 | ||
| Fwd PE | 15.44 | ||
| P/S | 0.5 | ||
| P/FCF | 13.93 | ||
| P/OCF | 6.24 | ||
| P/B | 0.61 | ||
| P/tB | 0.71 | ||
| EV/EBITDA | -0.02 |
EPS(TTM)0.6
EY5.04%
EPS(NY)0.77
Fwd EY6.48%
FCF(TTM)0.85
FCFY7.18%
OCF(TTM)1.91
OCFY16.01%
SpS23.83
BVpS19.35
TBVpS16.76
PEG (NY)2.17
PEG (5Y)583.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.35% | ||
| ROCE | 3.34% | ||
| ROIC | 2.75% | ||
| ROICexc | 4.77% | ||
| ROICexgc | 6.01% | ||
| OM | 3.04% | ||
| PM (TTM) | 2.72% | ||
| GM | 66.44% | ||
| FCFM | 3.58% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
ROICexc(3y)3.1%
ROICexc(5y)2.62%
ROICexgc(3y)3.7%
ROICexgc(5y)3.13%
ROCE(3y)2.85%
ROCE(5y)2.44%
ROICexcg growth 3Y17.7%
ROICexcg growth 5Y-1.56%
ROICexc growth 3Y17.75%
ROICexc growth 5Y-1.75%
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
F-Score6
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 2.62 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 112.46% | ||
| Cap/Sales | 4.41% | ||
| Interest Coverage | 15.15 | ||
| Cash Conversion | 114.87% | ||
| Profit Quality | 131.95% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 2.97 |
F-Score6
WACC6.4%
ROIC/WACC0.43
Cap/Depr(3y)97.27%
Cap/Depr(5y)108.32%
Cap/Sales(3y)4.24%
Cap/Sales(5y)5.08%
Profit Quality(3y)86.55%
Profit Quality(5y)290.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.07%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-31.25%
EPS Next Y9.14%
EPS Next 2Y10.96%
EPS Next 3Y11.09%
EPS Next 5Y12.28%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.34%
Revenue Next Year5.98%
Revenue Next 2Y4.97%
Revenue Next 3Y6.5%
Revenue Next 5Y5.94%
EBIT growth 1Y18.95%
EBIT growth 3Y16.29%
EBIT growth 5Y-3.2%
EBIT Next Year145.13%
EBIT Next 3Y44.3%
EBIT Next 5Y34.88%
FCF growth 1Y23.81%
FCF growth 3Y42.66%
FCF growth 5YN/A
OCF growth 1Y17.06%
OCF growth 3Y9.38%
OCF growth 5Y21.95%